Sanofi

Alopexx seeks $11M IPO to advance ex-Sanofi infectious disease drug
Fierce Biotech
Wed, 02/26/25 - 10:53 am
Alopexx
IPOs
Sanofi
Sanofi shows how $500M bowel disease bet compares to Merck and Roche's rival assets
Fierce Biotech
Mon, 02/24/25 - 11:32 am
Sanofi
Teva Pharmaceutical
Merck
Roche
clinical trials
duvakitug
IBD
inflammatory bowel disease
First biosimilar fast-acting insulin reaches US market
Pharmaphorum
Tue, 02/18/25 - 09:47 am
Sanofi
Novo Nordisk
Novolog
insulin
diabetes
biosimilars
Merilog
Sanofi, J&J abandon trial of E coli vaccine after poor data
Pharmaphorum
Thu, 02/13/25 - 11:38 am
JNJ
Sanofi
clinical trials
E. coli
vaccines
Regeneron tangles with Sanofi over commercial transparency in long-running Dupixent collaboration
Fierce Pharma
Thu, 02/6/25 - 10:50 pm
Regeneron
Sanofi
Dupixent
legal
Drugmakers prep for bird flu outbreak, despite continued low risk
Pharma Voice
Mon, 02/3/25 - 11:43 am
bird flu
vaccines
H5N1
Sanofi
GSK
Seqirus
Sanofi Plans €5 Billion Buyback, Sees Higher Profit Growth
Yahoo/Bloomberg
Thu, 01/30/25 - 10:55 am
Sanofi
earnings
Sanofi API plant hit with FDA warning letter detailing quality, consistency flubs
Fierce Pharma
Tue, 01/21/25 - 07:08 pm
Sanofi
drug manufacturing
FDA
Genzyme
Massachusetts
Could OTC Cialis for erectile dysfunction reach the US?
Pharmaphorum
Tue, 01/21/25 - 11:11 am
Sanofi
consumer healthcare
OTC
Opella
Cialis
erectile dysfunction
Sanofi to increase competition in atopic dermatitis market after Dupixent success
Clinical Trials Arena
Thu, 01/16/25 - 11:09 am
Sanofi
KT-474
Kymera Therapeutics
atopic dermatitis
Dupixent
JPM25: GSK, Sanofi CEOs welcome 'transparency' in response to anti-vaccine movement in US
Fierce Pharma
Tue, 01/14/25 - 06:21 pm
JPMHC 2025
Pharma CEOs
Sanofi
Paul Hudson
GSK
Emma Walmsley
vaccines
Sanofi scores with its subcutaneous version of Sarclisa as it tries to play catch up with J&J's Darzalex
Fierce Pharma
Thu, 01/9/25 - 11:55 am
JNJ
Darzalex
Sanofi
Sarclisa
Multiple Myeloma
LB Pharma's twist on old Sanofi drug passes schizophrenia test, teeing up phase 3 push
Fierce Biotech
Wed, 01/8/25 - 11:19 am
LB Pharma
schizophrenia
clinical trials
Sanofi
LB-102
5 FDA decisions to watch in the first quarter of 2025
BioPharma Dive
Mon, 01/6/25 - 06:54 pm
FDA
Vertex Pharmaceuticals
non-opioid pain treatments
suzetrigine
GSK
vaccines
MenABCWY
meningitis
Alnylam
vutrisiran
transthyretin amyloid cardiomyopathy
Soleno
diazoxide choline
Prader Willi syndrome
Sanofi
hemophilia
fitusiran
I-Mab pauses Sanofi-partnered prospect to make play for busy CLDN18.2 space
Fierce Biotech
Mon, 01/6/25 - 10:57 am
I-Mab
Sanofi
CLDN18.2
solid tumors
Drugmakers plan price hikes for 250+ medications in 2025
Beckers Hospital Review
Wed, 01/1/25 - 10:31 pm
drug pricing
Pfizer
Sanofi
Bristol Myers Squibb
Sanofi scoops up China rights to Cytokinetics’ heart disease med ahead of approval decision
Fierce Biotech
Fri, 12/20/24 - 11:26 am
Cytokinetics
Sanofi
China
aficamten
heart disease
Corxel Pharmaceuticals
FDA grants fast-track status to combination mRNA flu and COVID-19 vaccine candidates
Beckers Hospital Review
Tue, 12/17/24 - 12:09 pm
Sanofi
Novavax
COVID-19
vaccines
FDA
fast track
MRNA
Flu
Sanofi, Teva say study results show gut disease drug could be ‘best in class’
BioPharma Dive
Tue, 12/17/24 - 11:59 am
Sanofi
Teva Pharmaceutical
IBD
Merck
Roche
duvakitug
FDA Grants Breakthrough Therapy Designation to Sanofi’s Tolebrutinib for Non-Relapsing Secondary Progressive Multiple Sclerosis
Pharm Exec
Mon, 12/16/24 - 11:35 am
Sanofi
tolebrutinib
MS
non-relapsing secondary progressive MS
FDA

Pages